ConductScience.org, home

Library / Genes

GDE1: glycerophosphodiester phosphodiesterase 1

1 protein, 36 patents, 0 drugs, 0 trials, 3,065 NIH grants and 8,933 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolGDE1HGNC
Nameglycerophosphodiester phosphodiesterase 1HGNC
NCBI Gene ID51573NCBI Gene
HGNC IDHGNC:29644HGNC
EnsemblENSG00000006007NCBI Gene
Aliases363E6.2, MIR16NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q9NZC3Glycerophosphodiester phosphodiesterase 13310Ensembl, GeneID, HGNCUniProt

Patents 36

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1447976Q9NZC3Espacenet
EP 4650780 A22025-11-191880Q9NZC3Espacenet
JP 2025529142 A2025-09-041688Q9NZC3Espacenet
US 12371689 B22025-07-291688Q9NZC3Espacenet
JP 2025517970 A2025-06-121880Q9NZC3Espacenet
US 11446398 B22022-09-2035497Q9NZC3Espacenet
US 11400116 B22022-08-024265Q9NZC3Espacenet
JP 2022524081 A2022-04-27138468Q9NZC3Espacenet
US 11078247 B22021-08-034394Q9NZC3Espacenet
JP 2019054813 A2019-04-11228411Q9NZC3Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3065

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant382,025NIH's project files
P30CA016058Cancer Center Support Grant202,025NIH's project files
P30CA008748Cancer Center Support Grant132,025NIH's project files
P50CA127001SPORE in Brain Cancer132,025NIH's project files
P30CA016056Roswell Park Cancer Center Support Grant92,025NIH's project files
P30CA076292Moffitt Cancer Center Support Grant82,025NIH's project files
P30CA093373Cancer Center Support Grant P3072,025NIH's project files
P30CA015704Cancer Center Support Grant62,025NIH's project files
P30CA033572Cancer Center Support Grant62,025NIH's project files
P30CA043703Case Comprehensive Cancer Center Support Grant62,025NIH's project files

Papers 8933

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42795645PubTator, text miningPubMed
42749453PubTator, text miningPubMed
42640698PubTator, text miningPubMed
42604788PubTator, text miningPubMed
42597943PubTator, text miningPubMed
42552163PubTator, text miningPubMed
42508363PubTator, text miningPubMed
42498247PubTator, text miningPubMed
42448410PubTator, text miningPubMed
42434344PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license